PathGroup
NIH Awards $129M to Nine Dx Firms for Rapid COVID-19 Diagnostics
Some of the firms will receive money to speed up test development, while others will use the funds to expand their testing and manufacturing capacity.
PGDx, PathGroup to Co-Develop Genomic Profiling Assay
The firms will partner on studies needed to support and secure US regulatory approval for the Elio tissue complete assay.